Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
bins decrease » point decrease (Expand Search), sizes decrease (Expand Search), nn decrease (Expand Search)
Showing 1,481 - 1,500 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((bins decrease) OR (mean decrease)) ))', query time: 0.62s Refine Results
  1. 1481
    Table 1_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.xlsx

    Table 1_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.xlsx by Hong-Xing Li (316258)

    Published 2025
    “…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
    Save to List
    Saved in:
  2. 1482
    Image 9_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif

    Image 9_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif by Hong-Xing Li (316258)

    Published 2025
    “…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
    Save to List
    Saved in:
  3. 1483
    Image 4_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif

    Image 4_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif by Hong-Xing Li (316258)

    Published 2025
    “…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
    Save to List
    Saved in:
  4. 1484
    Image 2_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif

    Image 2_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif by Hong-Xing Li (316258)

    Published 2025
    “…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
    Save to List
    Saved in:
  5. 1485
    Table 3_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.xlsx

    Table 3_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.xlsx by Hong-Xing Li (316258)

    Published 2025
    “…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
    Save to List
    Saved in:
  6. 1486
    Image 1_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif

    Image 1_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif by Hong-Xing Li (316258)

    Published 2025
    “…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
    Save to List
    Saved in:
  7. 1487
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  8. 1488
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  9. 1489
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  10. 1490
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  11. 1491
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  12. 1492
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 1493
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 1494
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 1495
    Quality of life and Beck Depression Inventory baseline and post CRT+MRT, CRT and RUHB.

    Quality of life and Beck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1496
    Cardiorespiratory variable measurement of the study population.

    Cardiorespiratory variable measurement of the study population. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1497
    Description of the myofascial release techniques.

    Description of the myofascial release techniques. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1498
    ΔQuality of life and ΔBeck Depression Inventory baseline and post CRT+MRT, CRT and RUHB.

    ΔQuality of life and ΔBeck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1499
    Study flow diagram.

    Study flow diagram. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1500
    Changes in maximal strength within each group after treatment.

    Changes in maximal strength within each group after treatment. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: